Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial.
J Clin Oncol. 2023 Jan 10;41(2):385-394. doi: 10.1200/JCO.22.00393. Epub 2022 Sep 19.
J Clin Oncol. 2023.
PMID: 36122315
Free PMC article.
Clinical Trial.
Refining patient selection of MET-activated non-small cell lung cancer through biomarker precision.
Lai GGY, Guo R, Drilon A, Shao Weng Tan D.
Lai GGY, et al. Among authors: shao weng tan d.
Cancer Treat Rev. 2022 Nov;110:102444. doi: 10.1016/j.ctrv.2022.102444. Epub 2022 Aug 1.
Cancer Treat Rev. 2022.
PMID: 36108503
Free PMC article.
Review.
Item in Clipboard
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.
Tan EH, Lim WT, Ahn MJ, Ng QS, Ahn JS, Shao-Weng Tan D, Sun JM, Han M, Payumo FC, McKee K, Yin W, Credi M, Agarwal S, Jac J, Park K.
Tan EH, et al. Among authors: shao weng tan d.
Clin Pharmacol Drug Dev. 2018 Jun;7(5):532-542. doi: 10.1002/cpdd.427. Epub 2018 Jan 18.
Clin Pharmacol Drug Dev. 2018.
PMID: 29346833
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite